Skip to main content
Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.990
+0.110 (5.85%)
At close: Mar 9, 2026, 4:00 PM EDT
1.950
-0.040 (-2.01%)
After-hours: Mar 9, 2026, 7:50 PM EDT

Cardiff Oncology Revenue

In the year 2025, Cardiff Oncology had annual revenue of $593.00K, down -13.18%. Cardiff Oncology had revenue of $243.00K in the quarter ending December 31, 2025, with 60.93% growth.

Revenue (ttm)
$593.00K
Revenue Growth
-13.18%
P/S Ratio
229.42
Revenue / Employee
$19,129
Employees
31
Market Cap
136.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025593.00K-90.00K-13.18%
Dec 31, 2024683.00K195.00K39.96%
Dec 31, 2023488.00K102.00K26.42%
Dec 31, 2022386.00K27.00K7.52%
Dec 31, 2021359.00K-7.00K-1.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spero Therapeutics 40.55M
Sangamo Therapeutics 32.88M
Oramed Pharmaceuticals 2.00M
Connect Biopharma Holdings 762.00K
Inovio Pharmaceuticals 182.34K
Adagene 103.20K
Genelux 8.00K
Revenue Rankings

CRDF News

More News